arrow_back Back to App

Alpha-1 Antitrypsin Deficiency Awareness Month: Boosting Disease Knowledge

The U.S. Senate supports designating November 2022 as National Alpha-1 Antitrypsin Deficiency Awareness Month. The goal is to increase public knowledge about this genetic disorder, which can lead to severe lung and liver issues, and to encourage testing. Greater awareness can aid in earlier detection and prevention of disease progression.
Key points
November 2022 was designated Alpha-1 Antitrypsin Deficiency Awareness Month to educate the public about this genetic condition.
The initiative aims to encourage individuals with symptoms to get a simple blood test that can confirm diagnosis.
Early detection and avoiding risk factors like smoking can prevent severe health consequences related to Alpha-1 deficiency.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_SRES_792
Sponsor: Sen. Scott, Rick [R-FL]
Process start date: 2022-09-22
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

A resolution expressing support for the designation of November 2022 as "National Alpha-1 Antitrypsin Deficiency Awareness Month".

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_SRES_792.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2022-09-22.

What are the main provisions?

Key points include:

  • November 2022 was designated Alpha-1 Antitrypsin Deficiency Awareness Month to educate the public about this genetic condition.
  • The initiative aims to encourage individuals with symptoms to get a simple blood test that can confirm diagnosis.
  • Early detection and avoiding risk factors like smoking can prevent severe health consequences related to Alpha-1 deficiency.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Scott, Rick [R-FL].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

CATEGORIES

Health